Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 recovery can lead to temporary hair loss called telogen effluvium.

COVID-19 can cause skin issues like "COVID toes," rashes, hair loss, and hand eczema, and dermatologists are important for recognizing these signs.

Hormones affect skin aging, and treatments targeting hormonal balance may improve skin health.

Chemotherapy in the first trimester of pregnancy is risky, but in the second and third trimesters, it's generally safe with careful drug selection and timing.

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.

Middle-aged women with chronic telogen effluvium experience increased hair shedding but usually don't get significantly thinner hair.

Chemotherapy-induced hair loss significantly affects patients' well-being, and nurses are key in helping them cope, but more research is needed to find effective treatments.

Modern lifestyles, including poor diet, stress, and long-term use of certain medications, hinder the body's ability to heal from inflammation, leading to chronic diseases.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Acne is caused by genetics, diet, hormones, and bacteria, with treatments not yet curative.

Lithium therapy may cause skin problems like hidradenitis suppurativa and other side effects, which can improve after stopping the medication.

Some medications can cause hair loss, but stopping the drug usually leads to recovery within 3 months.

Some patients developed skin inflammation after obesity surgery, and a medication called dapsone helped treat it.

Toxic epidermal necrolysis is a severe skin reaction often linked to drugs, requiring careful medication use and supportive care.

COVID-19 may cause hair loss due to infection stress or treatments.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Different types of hair loss in lupus need careful diagnosis for proper treatment.

Autoimmune diseases can cause hair loss, and early treatment is important to prevent permanent damage.

Stress and emotional factors can worsen skin conditions by affecting the immune system.

The document concludes that terbinafine is effective for treating scalp fungal infections in children and recommends not excluding them from school during treatment, while also highlighting the need for updated treatment guidelines due to changing infection patterns.

Psychotropic medications can cause skin reactions, including severe conditions like SJS and TEN, and it's important for psychiatrists to recognize and manage these side effects.

The document concludes that treating tough skin disease in lupus involves sun protection, steroids, antimalarials, and various other therapies chosen based on individual risks and benefits.

Lupus can look like hair loss from alopecia areata but needs different treatment.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

Minoxidil may cause heart changes; use caution and monitor patients with heart conditions.

COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.

Trichoscopy is good for telling apart tinea capitis and alopecia areata in kids.

Long COVID patients may have hormonal imbalances linked to their symptoms.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.